Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
- 10 March 2010
- journal article
- clinical trial
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (8) , 1420-1424
Abstract
Recently, dynamic contrast-enhanced magnetic resonance imaging has been shown to be a non-invasive technique that provides global and functional imaging of bone marrow angiogenesis in acute myeloid leukemia. To assess the clinical implication of changes in angiogenesis shortly after induction chemotherapy, dynamic contrast-enhanced magnetic resonance imaging was performed prospectively before treatment (day 0) and on day 7 in 80 patients with de novo acute myeloid leukemia. We demonstrated that a post-therapeutic reduction in Peak (negative DeltaPeak) compared with the day 0 value was significantly associated with a higher chance of achieving complete remission, and better overall and disease free survival (P=0.022, 0.003 and 0.007, respectively). Cox's multivariate analysis also identified negative DeltaPeak value as an independent good prognostic factor for overall and disease free survival. Our findings provide evidence that the change of Peak on day 7 relative to pre-treatment levels may be a relevant biomarker for early identification of patients who may fail conventional induction chemotherapy (ClinicalTrials.gov Identifier: NCT00172562).Keywords
This publication has 21 references indexed in Scilit:
- Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survivalBlood, 2009
- Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemiaLeukemia Research, 2008
- Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionBlood, 2006
- Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemiaLeukemia, 2005
- Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR ImagingJournal of Computer Assisted Tomography, 1991
- Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsMagnetic Resonance in Medicine, 1991
- Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant diseaseLeukemia Research, 1988
- Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemiaLeukemia Research, 1987
- Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurementsBritish Journal of Haematology, 1986
- Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsyLeukemia Research, 1983